MAPT and schizophrenia: While the function of plasma levels of exosomal Aβ and tau and their relationship to CSF protein levels have not been fully elucidated, these markers may be an innovative and relatively non-invasive approach to understanding Aβ and tau in the people with schizophrenia and other psychiatric disorders.